Literature DB >> 27354676

Improving patient-centred care for rheumatoid arthritis.

Nick Bansback1, Kam Shojania2, Diane Lacaille2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27354676      PMCID： PMC5047811          DOI： 10.1503/cmaj.160051

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Shared decision making--pinnacle of patient-centered care.

Authors:  Michael J Barry; Susan Edgman-Levitan
Journal:  N Engl J Med       Date:  2012-03-01       Impact factor: 91.245

2.  Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial.

Authors:  Ronald F van Vollenhoven; Pierre Geborek; Kristina Forslind; Kristina Albertsson; Sofia Ernestam; Ingemar F Petersson; Katerina Chatzidionysiou; Johan Bratt
Journal:  Lancet       Date:  2012-03-29       Impact factor: 79.321

Review 3.  Stop the silent misdiagnosis: patients' preferences matter.

Authors:  Albert G Mulley; Chris Trimble; Glyn Elwyn
Journal:  BMJ       Date:  2012-11-08

4.  Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.

Authors:  Vivian P Bykerk; Pooneh Akhavan; Glen S Hazlewood; Orit Schieir; Anne Dooley; Boulos Haraoui; Majed Khraishi; Sharon A Leclercq; Jean Légaré; Diane P Mosher; James Pencharz; Janet E Pope; John Thomson; Carter Thorne; Michel Zummer; Claire Bombardier
Journal:  J Rheumatol       Date:  2011-09-15       Impact factor: 4.666

5.  A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.

Authors:  Jasvinder A Singh; Robin Christensen; George A Wells; Maria E Suarez-Almazor; Rachelle Buchbinder; Maria Angeles Lopez-Olivo; Elizabeth Tanjong Ghogomu; Peter Tugwell
Journal:  CMAJ       Date:  2009-11-02       Impact factor: 8.262

6.  Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.

Authors:  J R O'Dell; C E Haire; N Erikson; W Drymalski; W Palmer; P J Eckhoff; V Garwood; P Maloley; L W Klassen; S Wees; H Klein; G F Moore
Journal:  N Engl J Med       Date:  1996-05-16       Impact factor: 91.245

7.  Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis.

Authors:  L H D van Tuyl; A M C Plass; W F Lems; A E Voskuyl; P J S M Kerstens; B A C Dijkmans; M Boers
Journal:  Rheumatology (Oxford)       Date:  2008-08-18       Impact factor: 7.580

8.  Therapies for active rheumatoid arthritis after methotrexate failure.

Authors:  James R O'Dell; Ted R Mikuls; Thomas H Taylor; Vandana Ahluwalia; Mary Brophy; Stuart R Warren; Robert A Lew; Amy C Cannella; Gary Kunkel; Ciaran S Phibbs; Aslam H Anis; Sarah Leatherman; Edward Keystone
Journal:  N Engl J Med       Date:  2013-06-11       Impact factor: 91.245

9.  When Patients Write the Guidelines: Patient Panel Recommendations for the Treatment of Rheumatoid Arthritis.

Authors:  Liana Fraenkel; Amy S Miller; Kelly Clayton; Rachelle Crow-Hercher; Shantana Hazel; Britt Johnson; Leslie Rott; Whitney White; Carole Wiedmeyer; Victor M Montori; Jasvinder A Singh; W Benjamin Nowell
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-11-06       Impact factor: 4.794

10.  A retrospective cohort study: 10-year trend of disease-modifying antirheumatic drugs and biological agents use in patients with rheumatoid arthritis at Veteran Affairs Medical Centers.

Authors:  Bernard Ng; Adeline Chu; Myrna M Khan
Journal:  BMJ Open       Date:  2013-04-05       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.